India Drugs
-
{
- All
- News
- Videos
- Web Stories
-
Fake Weight Loss Drug Racket Busted In Gurugram, 2 Arrested
Authorities arrest two in Gurugram for making and selling fake Mounjaro injections.
-
IIT Gandhinagar Develops Hydrogel-Based Technology To Simplify Colon Tumour Surgery
Gandhinagar, April 19 (IANS) In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further innovations -- thereby resulting in "simplification" of surgery for colon-related tumours.
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Alzheimer's Amyloid-Targeting Drugs Show No Clear Clinical Benefit: Review
Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but it has no clinically meaningful positive effects, according to a new review of previously published studies has found.
-
Fake Weight Loss Injections Are Flooding The Market; Doctors Warn Patients Of Serious Health Risks
Fake weight loss injections are flooding the market, posing serious health risks. Dr Ravi Malik and Dr Shilpa Bhatte explain in depth about the prevalence of fake weight loss injections and how to safeguard yourself.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
India Strengthens Pharmaceutical Sector, Shifts Focus To Innovation-Led Drug Development: Experts
New Delhi, April 14 (IANS) While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ecosystem collaboration, and a shift towards innovation-led development to position the country as
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
Fake Weight Loss Drug Racket Busted In Gurugram, 2 Arrested
Authorities arrest two in Gurugram for making and selling fake Mounjaro injections.
-
IIT Gandhinagar Develops Hydrogel-Based Technology To Simplify Colon Tumour Surgery
Gandhinagar, April 19 (IANS) In a landmark achievement, the IIT Gandhinagar has developed a hydrogel-based technology with potential of spurring further innovations -- thereby resulting in "simplification" of surgery for colon-related tumours.
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Alzheimer's Amyloid-Targeting Drugs Show No Clear Clinical Benefit: Review
Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but it has no clinically meaningful positive effects, according to a new review of previously published studies has found.
-
Fake Weight Loss Injections Are Flooding The Market; Doctors Warn Patients Of Serious Health Risks
Fake weight loss injections are flooding the market, posing serious health risks. Dr Ravi Malik and Dr Shilpa Bhatte explain in depth about the prevalence of fake weight loss injections and how to safeguard yourself.
-
Natural Ozempic, No Side Effects: Stanford Scientists Discover Peptide That Can Rival The GLP-1 Drug
One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool called "Peptide Predictor" to scan all human protein-coding genes.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
India Strengthens Pharmaceutical Sector, Shifts Focus To Innovation-Led Drug Development: Experts
New Delhi, April 14 (IANS) While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ecosystem collaboration, and a shift towards innovation-led development to position the country as
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
